Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 176   

Articles published

GSK 1,405.95 -30.55 (-2.13%)
price chart
GlaxoSmithKline plc's Buy Rating Reaffirmed at Galvan Research (GSK)
GlaxoSmithKline plc (LON:GSK)'s stock had its �buy� rating reaffirmed by stock analysts at Galvan Research in a report issued on Friday.
GlaxoSmithKline plc Receives �Hold� Rating from Liberum Capital (GSK)  Intercooler
Recent Analysts' Ratings Updates for GlaxoSmithKline plc (GSK)  Mideast Time
Related articles »  
How GlaxoSmithKline plc Can Pay Off Your Mortgage
gsk It's been a pretty tough year for investors in GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US). That's because shares in the pharmaceutical company have fallen by 11% during the course of 2014, while the FTSE 100 is up 1% over the same time period.
GlaxoSmithKline plc Rating Lowered to Underperform at Mainfirst (GSK)  Ticker Report
Related articles »  
GlaxoSmithKline plc And Reckitt Benckiser plc Aim To Unlock Value
The pharma sector is in upheaval, with massive deals making weekly headlines and companies taking evasive action to pre-empt the advances of predators.
GlaxoSmithKline plc (GSK), Genmab Report PROLONG Phase III Met Primary ...
GlaxoSmithKline plc (NYSE: GSK) and Genmab A/Sannounced that an Independent Data Monitoring Committee (IDMC) interim analysis of a Phase III study, PROLONG (OMB 112517), reached the predefined significance level for efficacy (p<=0.001).
Genmab A/S - GSK and Genmab Announce Positive Interim Result for Phase III ...  Wall Street Journal
GSK and Genmab Announce Positive Interim Result for Phase III Study of ...  NASDAQ
Related articles »  
What Investors Are Missing With GlaxoSmithKline plc
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) shares have been hammered since the company said it would post no sales or profit growth in the year ahead after all, but what is much more important for the long term is the reshaping taking place - and the ...
What You Were Buying Last Week: GlaxoSmithKline plc  Motley Fool UK
GlaxoSmithKline plc Downgraded to Neutral at Bank of America (GSK)  Intercooler
Related articles »  
Will GlaxoSmithKline plc Split Itself In Two?
GlaxoSmithKline's (LSE: GSK) (NYSE: GSK.US) management is working hard to overhaul the FTSE 100′s largest listed pharmaceutical company, after a wave of bad news last year.
GlaxoSmithKline plc Falls On Drop In Profits And Turnover
The share price of GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is currently down over 3% following publication of a results announcement for the second quarter and interim management report for the half-year.
Is GlaxoSmithKline plc A Safe Dividend Investment?  Yahoo Finance UK
GlaxoSmithKline plc trims 2014 forecast  ValueWalk
Related articles »  
GlaxoSmithKline plc Receives Hold Rating from Jefferies Group (GSK)
Jefferies Group reissued their hold rating on shares of GlaxoSmithKline plc (LON:GSK) in a research note released on Friday morning.
Eyes Down For GlaxoSmithKline plc Results
gsk GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been overshadowed a bit of late by takeover attempts at rival AstraZeneca, and its share price has lagged a little - it's been see-sawing all year and is down around 8% over the past 12 months, ...
Related articles »  
Best Pharma Stocks Not In The U.S. [GlaxoSmithKline plc (ADR), AbbVie Inc ...
1 Must Own Pharma Stock: GlaxoSmithKline PLC (NYSE: GSK). As mentioned, one of the more enticing aspects to these international drug companies is there �cheapness� relative to U.S.